Bone morphogenetic protein 6 expression in oral cavity squamous cell cancer is associated with bone invasion

Laryngoscope

Volumn 123, Issue 12, 2013, Pages 3061-3065

  Kejner, Alexandra E ^a   Burch, M Benjamin ^a   Sweeny, Larissa ^a   Rosenthal, Eben L ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

bone morphogenetic protein 6; Head and neck; immunohistochemistry; oral cavity cancer; squamous cell carcinoma; tumor biomarkers

Indexed keywords

BONE MORPHOGENETIC PROTEIN 6; CD147 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR;

BONE METASTASIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL SURVIVAL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFERENCE PAPER; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MEDICAL RECORD REVIEW; MOUTH SQUAMOUS CELL CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERINEURAL INVASION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

BONE MORPHOGENETIC PROTEIN-6; HEAD AND NECK; IMMUNOHISTOCHEMISTRY; ORAL CAVITY CANCER; SQUAMOUS CELL CARCINOMA; TUMOR BIOMARKERS;

ADULT; AGED; BONE MORPHOGENETIC PROTEIN 6; BONE NEOPLASMS; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84888432390     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24267     Document Type: Conference Paper

References (18)

1. Wang CC, Cheng MH, Hao SP, Wu CC, Huang SS,. Osteoradionecrosis with combined mandibulotomy and marginal mandibulectomy. Laryngoscope 2005; 115: 1963-1967.
2. Ebrahimi A, Murali R, Gao K, Elliott MS, Clark JR,. The prognostic and staging implications of bone invasion in oral squamous cell carcinoma. Cancer 2011; 117: 4460-4467.
3. Bilodeau EA, Chiosea S,. Oral squamous cell carcinoma with mandibular bone invasion: intraoperative evaluation of bone margins by routine frozen section. Head Neck Pathol 2011; 5: 216-220.
4. Abd El-Hafez YG, Chen CC, Ng SH, et al. Comparison of PET/CT and MRI for the detection of bone marrow invasion in patients with squamous cell carcinoma of the oral cavity. Oral Oncol 2011; 47: 288-295.
5. Chen HH, Chen IH, Liao CT, Wei FC, Lee LY, Huang SF,. Preoperative circulating C-reactive protein levels predict pathological aggressiveness in oral squamous cell carcinoma: a retrospective clinical study. Clin Otolaryngol 2011; 36: 147-153.
6. Huang SF, Cheng SD, Chien HT, et al. Relationship between epidermal growth factor receptor gene copy number and protein expression in oral cavity squamous cell carcinoma. Oral Oncol 2012; 48: 67-72.
7. Seki S, Fujiwara M, Matsuura M, et al. Prediction of outcome of patients with oral squamous cell carcinoma using vascular invasion and the strongly positive expression of vascular endothelial growth factors. Oral Oncol 2011; 47: 588-593.
8. Erdem NF, Carlson ER, Gerard DA, Ichiki AT,. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials. J Oral Maxillofac Surg 2007; 65: 1725-1733.
9. Chen YJ, Jin YT, Shieh DB, Tsai ST, Wu LW,. Molecular characterization of angiogenic properties of human oral squamous cell carcinoma cells. Oral Oncol 2002; 38: 699-705.
10. Raida M, Sarbia M, Clement JH, Adam S, Gabbert HE, Hoffken K,. Expression, regulation and clinical significance of bone morphogenetic protein 6 in esophageal squamous-cell carcinoma. Int J Cancer 1999; 83: 38-44.
11. Autzen P, Robson CN, Bjartell A, et al. Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies. Br J Cancer 1998; 78: 1219-1223.
12. Darby S, Cross SS, Brown NJ, Hamdy FC, Robson CN,. BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype. J Pathol 2008; 214: 394-404.
13. Zhang M, Yan JD, Zhang L, et al. Activation of bone morphogenetic protein-6 gene transcription in MCF-7 cells by estrogen. Chin Med J (Engl) 2005; 118: 1629-1636.
14. Dai J, Keller J, Zhang J, Lu Y, Yao Z, Keller ET,. Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism. Cancer Res 2005; 65: 8274-8285.
15. Allred DC, Harvey JM, Berardo M, Clark GM,. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998; 11: 155-168.
16. Jerjes W, Upile T, Petrie A, et al. Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients. Head Neck Oncol 2010; 2: 9-30.
17. Viana L, Affonso R, Silva S, et al. Relationship between the expression of the extracellular matrix genes SPARC, SPP1, FN1, ITGA5 and ITGAV and clinicopathological parameters of tumor progression and colorectal cancer dissemination. Oncology 2013; 84: 81-91.
18. Yuen H, McCrudden C, Grills C, et al. Combinatorial use of bone morphogenetic protein 6, noggin, and Sost significantly predicts cancer progression. Cancer Sci 2012; 103: 1145-1154.